Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment; REGENERATE

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleRandomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment; REGENERATE
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsEric J Lawitz
View all 1
View less